RRAGD and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: Taken together, our results suggest that RRAGC and/or RRAGD may contribute to mTORC1 signaling in tRCC but are likely not the only mechanism leading to increased mTORC1 activity.